L
Larimar Therapeutics, Inc. Common StockLRMR
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar's lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's.
US StocksHealthcareSmall CapBiotechnology
LRMR の価格トレンド
Larimar Therapeutics, Inc. Common Stock · TradingView フルチャート
NASDAQ:LRMR